ANGPTL3 and familial hyperaldosteronism: Treatment of homozygous FH is more difficult than heterozygous FH and involves newer therapies (inhibitors of microsomal triglyceride transfer protein and angiopoietin-like protein 3), lipoprotein apheresis, and very rarely liver transplantation [10].